1. The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer’s Disease: Implications for Treatment
- Author
-
Fang Xie, Shibo Zhang, Jiao Wang, Ruiqing Ni, Lin Huang, Weiyan Zhou, Weihao Li, Xuanting Liu, Yinping Zhou, Cuiping Liu, Chencheng Zhang, Yanyan Kong, Donglang Jiang, Bomin Sun, Zhang Zhengwei, and Yihui Guan
- Subjects
0301 basic medicine ,Apolipoprotein E ,QH301-705.5 ,Alzheimer's disease ,Neurodegeneration ,Synaptic vesicle protein 2A ,Tau ,Aβ ,PI3K signaling pathway ,Tau protein ,Biology ,Synaptic vesicle ,03 medical and health sciences ,Cell and Developmental Biology ,0302 clinical medicine ,Downregulation and upregulation ,medicine ,Amyloid precursor protein ,Biology (General) ,SV2A ,Original Research ,Cell Biology ,medicine.disease ,Cell biology ,030104 developmental biology ,biology.protein ,Signal transduction ,Alzheimer’s disease ,030217 neurology & neurosurgery ,Developmental Biology - Abstract
Alzheimer’s disease (AD), a serious neurodegenerative disease, is pathologically characterized by synaptic loss and dysfunction. Synaptic vesicle protein 2A (SV2A) is an indispensable vesicular protein specifically expressed in synapses and can be used as a biomarker for synaptic density. We found that the expression of SV2A was down-regulated in the hippocampus of AD patients, yet the relation of SV2A to other hallmarks of AD pathology such as amyloid precursor protein (APP), β-amyloid (Aβ), and Tau protein is not thoroughly clear. In addition, SV2A colocalized with APP and was down-regulated at Aβ deposition. Moreover, we found that SV2A deficiency leads to a simultaneous increase in Aβ and Tau hyperphosphorylation, while SV2A overexpression was associated with downregulation of β-site APP cleaving enzyme 1 and apolipoprotein E genes. In addition, evidence gained in the study points to the phosphatidylinositol 3-kinase signaling pathway as a possible mediator in SV2A regulation influencing the incidence and development of AD. With limited effective diagnostic methods for AD, a close interplay between SV2A and AD-related proteins demonstrated in our study may provide novel and innovative diagnostic and therapeutic opportunities., Frontiers in Cell and Developmental Biology, 9, ISSN:2296-634X
- Published
- 2021
- Full Text
- View/download PDF